Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Mirtel

Mirtel
2012 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
2 INVESTORS
Description

Provider of clinical and gene testing services. The company performs laboratory tests on public health and facilities the provision of clinical examination to detect genetic disorder such as Alzheimer's disease and exosomes.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Other Pharmaceuticals and Biotechnology
Primary Office
  • Shiodome 1-2-10-101
  • Minami-ku
  • Hiroshima, 734-0001
  • Japan

+81 000-000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Mirtel’s full profile, request a free trial.

Mirtel Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 17-Nov-2012 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Mirtel Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
NTT Docomo Ventures Corporate Venture Capital Minority 000 0000 000000 0
The University of Tokyo Edge Capital Venture Capital Minority 000 0000 000000 0

Mirtel Executive Team (1)

Name Title Board
Seat
Contact
Info
Eiji Tahara Chief Executive Officer, President & Board of Directors

Mirtel Board Members (4)

Name Representing Role Since Contact
Info
Eiji Tahara Mirtel Chief Executive Officer, President & Board of Directors 000 0000
Tahara SakaeShun Mirtel Founder & Chairman 000 0000
Yoshihiro Kuwamoto Mirtel Board of Directors 000 0000

1 Former Board Member

You’re viewing 3 of 4 board members. Get the full list »